Непосредственные результаты предоперационной химиотерапии по схеме FLEP и хирургического лечения у больных раком грудного отдела пищевода
Диссертация
Было показано, что схема PELF весьма результативна в лечении рака пищевода, особенно при локализованном поражении, — частота эффективности составила 45%. Из вышесказанного можно сделать вывод, что неоадьювантная химиотерапия в сочетании с операцией может приводить к улучшению результатов хирургического лечения и увеличивать продолжительность жизни пациентов. В рандомизированном исследовании… Читать ещё >
Содержание
- ГЛАВА I. ПРЕДОПЕРАЦИОННАЯ СПЕЦИАЛЬНАЯ ТЕРАПИЯ У БОЛЬНЫХ РАКОМ ГРУДНОГО ОТДЕЛА ПИЩЕВОДА (ОБЗОР ЛИТЕРАТУРЫ)
- Предоперационная лучевая терапия
- Предоперационная химиотерапия
- Предоперационная химиолучевая терапия
- Методы диагностики первичной распространенности и эффекта предоперационного лечения у больных раком грудного отдела пищевода
- Недостатки завершенных клинических испытаний
Список литературы
- Давыдов М.И. Одномоментные операции в хирургическом и комбинированном лечении рака пищевода. // Дисс. докт. мед. наук.— М., 1988.
- Давыдов М.И., Стилиди И. С., Сатыбалдиев Т. Д., Шамилов А. З., Доляр Д. Г., Бейшембаев М. И., Макишев А. К. Оценка эффективности химиолучевой терапии неоперабельного рака пищевода. // Тезисы I Съезда онкологов стран СНГ.— М., декабрь 1996.— Ч. 1.— С. 288.
- Двойрин В.В., Аксель Е. М., Трапезников Н. Н. Заболеваемость злокачественными новообразованиями и смертность от них населения стран СНГ,—М., 1996.
- Кухаренко В.М. Сравнительная оценка хирургического и комбинированного лечения рака грудного отдела пищевода. // Дисс.. докт. мед. наук.— М., 1989.
- Мамонтов А.С., Верещагин В. Г. Результаты хирургического лечения рака грудного отдела пищевода. // Хирургия.— 1986.— № 7.— С. 93−98.
- Мамонтов А.С., Симанчев В. Н. Хирургическое, лучевое и комбинированное лечение местнораспространенного рака пищевода. // Хирургия.— 1975, — № 9.— С. 40−43.
- Мацнева H.JI. Комплексная диагностика рака пищевода до и после лечения. // Дисс. канд. мед. наук.— М., 1991.
- Плесков А.П., Стилиди И. С., Мазурина О. С., Ломидзе С. В. Структура ранних послеоперационных осложнений у больных раком пищевода. // Анналы Московского онкологического общества.— 1997.— № 2.— С. 47.
- Чиссов В.И. Комбинированное и комплексное лечение больных со злокачественными опухолями.— М.: Медицина.— 1989.— С. 290−310.
- Adelstein D.J., Шее T.W., Becker M., Larto M.A., Kirby Т.J., Кока A. et al. Use of concurrent chemotherapy, accelerated fractionation radiation and surgery for patients with esophageal carcinoma. // Cancer.— 1997.— V. 80.— P. 1011−1020.
- Aibe Т., Ito Т., Yoshita T. et al. Endoscopic ultrasonography of lymph nodes surrounding the upper GI tract. // Scand. J. Gastroenterol.— 1986.— Suppl. 123.— V. 21,—P. 164.
- Ajani J.A., Ilson D.H., Daugherty K., et al. Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus. // J. Natl. Cancer Inst.— 1994.—V. 86.—P. 1086−1091.
- Ajani J.A., Roth J.A., Ryan В., et al. Evaluation of pre- and post-operative chemotherapy for resectable adenocarcinoma of the esophagus or gastroesophageal junction.//J. Clin. Oncol.— 1990.—V. 8.—P. 1231−1238.
- Altorki N., Kent M., Ferrara C., Port J. Three-field lymph node dissection for squamous cell and adenocarcinoma of the oesophagus. // Ann. Surg.— 2002.— V. 236.—P. 177−183.
- Altorki N., Skinner D. Should en bloc esophagectomy be the standard of care for esophageal carcinoma? // Ann. Surg. — 2001.— V. 234.— P. 581−587.
- Altorki N.K., Girardi L., Skinner D.B. En bloc esophagectomy improves survival for stage III esophageal cancer. // J. Thorac. Cardiovasc. Surg.— 1997.— V. 114.—P. 948−956.
- Amar D., Burt M.E., Bains M.S., Leung D.H. Symptomatic tachydysrhythmias of oesophagectomy: incidence and outcome measures. // Ann. Thorac. Surg.— 1996,—V. 61,—P. 1506−1509.
- American Joint Committee on Cancer. AJCC cancer staging handbook. // 6th ed. Philadelphia: Lippincott-Raven, 2002 — P. 3−8.
- Andersen A.P., Berdal P., Hagen S., Hatlevoll R. Irradiation, chemotherapy and surgery in esophageal cancer: a randomized clinical study. The first Scandinavian trial in esophageal cancer. // Radiother. Oncol.— 1984.— V. 2, — P. 179−188.
- Ando N., Ozawa S., Miki H., Suwa Т., Kitajima M. Neoadjuvant chemotherapy and chemoradiotherapy in the treatment of esophageal cancer. // Gan. Kagaku Ryoho. — 1995.— V. 22.— P. 1878−1885 (in Japanese).
- Apinop C., Puttisak P., Preecha N. A prospective study of combined therapy in esophageal cancer. // Hepatogastroenterology.— 1994.— V. 41.— P. 391−3.
- Araujo C.M., Souhami L., Gil R.A. et al. A randomized trial comparing radiation therapy versus concomitant radiation therapy and chemotherapy in carcinoma of the thoracic esophagus. // Cancer.— 1991.— V. 67.— P. 2258−2261.
- Archer V.R., Mulholland P.J., Stocken D.D. et al. Combined results from three phase II trials of neoadjuvant chemotherapy in operable adenocarcinoma of the oesophagus. // Clin. Oncol. (R. Coll. Radiol.).— 2001, — V. 13, — P. 164−169.
- Arnott S.J., Duncan W., Gignoux M., et al. Preoperative radiotherapy in esophageal carcinoma: a meta-analysis using individual patient data (Oesophageal Cancer Collaborative Group). // Int. J. Radiation. One. Biol. Phys.— 1998.— V. 41.—P. 579−583.
- Avendano C.E., Flume P.A., Silvestri G.A., King L.B. Pulmonary complications afteroesophagectomy. //Ann. Thorac. Surg.—2002.—V. 73—P. 922−926.
- Bains M.S., Stojadinovic A., Minsky B. et al. A phase II trial of preoperative combined-modality therapy for localized esophageal carcinoma: initial results. // J. Thorac. Cardiovasc. Surg.— 2002.— V. 124, — P. 270−277.
- Bates B.A., Detterbeck F.C., Bernard S.A., et al. Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma. //J. Clin. Oncol.— 1996.—V. 14,—P. 156−163.
- Beahrs O.H., Henson D.E., Hutter R.V.P. American Joint Committee on Cancer. Manual for staging cancer. 4th ed. Philadelphia.— JB Lippincott, 1992.
- Bedenne L., Faivre J., Boutron M-C., et al. Le cancer de l’oesophage dans le departement de la Cote-d'Or. // Bull. Cancer.— 1986.— V. 73.— P. 526−34.
- Begg C., Cho M., Eastwood S., Horton R., Moher D., Olkin I. et al. Improving the quality of reporting of randomized controlled trials. The CONSORT Statement. // JAMA.— 1996.— V. 276.— P. 637−639.
- Beseth B.D., Bedford R., Isacoff W.H. et al. Endoscopic ultrasound does not accurately assess pathologic stage of esophageal cancer after neoadjuvant chemoradiotherapy. // Am. Surg.— 2000.— V. 66.— P. 827−831.
- Binmoeller K.F., Seifert H., Soehendra N. Endoscopic ultrasonography-guided fine-needle aspiration biopsy of lymph nodes. // Endoscopy.— 1994.— V. 26 (9).—P. 780−783.
- Bleiberg H., Jacob J.H., Bedenne I. et al. Randomized phase II trial of 5-fluouracil (5FU) and cisplatin (DDP) vs. DDP alone in advanced esophageal cancer (abstract). // Proc. ASCO.— 1991.— V. 10.— A447.
- Block M.I., Patterson G.A., Sundaresan R.S., et al. Improvement in staging of esophageal cancer with the addition of positron emission tomography. // Ann. Thorac. Surg.— 1997, — V. 64.—P. 770−777.
- Blot W.J., Devesa S.S., Kneller R.W., Fraumeni J.F. Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. // JAMA.— 1991.— V. 265.—P. 1287−1289.
- Bosset J-F., Gignoux M., Triboulet J-P., et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell carcinoma of the esophagus. //N. Engl. J. Med.— 1997,—V. 337.—P. 161−167.
- Bosset J-F., Mercier M., Triboulet J.P., Conroy Т., Seitz J.F. Surgical resection with and without chemotherapy in oesophageal cancer. // The Lancet.— 2002.— V. 360.— V. 1173−1174.
- Botet J.F., Lightdale C.J., Zauber A.G., et al. Preoperative staging of esophageal cancer: comparison of endoscopic and dynamic CT. // Radiology.— 1991.—V. 181.—P. 419−425.
- Calament G., Cauvin J-M., Robaszkiewicz M., et al. Traitement et survie du cancer epidermoide de l’oesophage dans le departement du Finistere entre 1984 et 1988 (716 cas). // Gastroenterol. Clin. Biol.— 1993.—V. 17.—P. 9−16.
- Campbell W.R. Jr, Taylor S.A., Pierce G.E., Hermreck A.S., Thomas J.H. Therapeutic alternatives in patients with esophageal cancer. // Am. J. Surg.— 1985.—V. 150.—P. 665−668.
- Carey R.W., Hilgenberg A.D., Grillo H.C., et al. Esophageal cancer: long-term follow-up of patients treated by neoadjuvant chemotherapy, surgery and possible postoperative radiation and/or chemotherapy. // Proc. ASCO.— 1990.— V. 9.— P. 105.
- Catalano M.F., Sivac M.J., Rice Т., Gragg L.A., Van D.J. Endosonographic features predictive of lymph node metastasis. // Gastrointest. Endosc.— 1994.— V. 40 (4).—P. 442−446.
- Catalano M.F., Van D.J., Sivac M.J. Malignant esophageal strictures: staging accuracy of endoscopic ultrasonography. // Gastrointest. Endosc.— 1995.—V. 41 (6).—P. 535−539.
- Chak A., Canto M.I., Cooper G.S., et al. Endosonographic assessment of multimodality therapy predicts survival of esophageal carcinoma patients. // Cancer.—2000.—V. 88.—P. 1788−1795.
- Cherie-Challine L., Pottier D., Gignoux M. Epidemiologie descriptive du cancer de l’oesophage dans le departement du Calvados: 520 cas (1978−1982). // Gastroenterol. Clin. Biol.— 1988,—V. 12.—P. 126−32.
- Coia L.R., Engstrom P.F., Paul A.R. et al. Long-term results of infusional 5-FU, mitomycin-C and radiation as primary management of esophageal carcinoma. // Int. J. Radiat. Oncol. Biol. Phys.— 1991, — V. 20.— P. 29−36.
- Coia L.R., Soffen E.M., Schultheiss Т.Е., Martin E.E., Hanks G.E. Swallowing function in patients with esophageal cancer treated with concurrent radiation and chemotherapy. // Cancer.— 1993.— V. 71.— P. 281−286.
- Cooper J.S., Guo M.D., Herskovic A. et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85−01). Radiation Therapy Oncology Group. // JAMA.— 1999.— V. 281,—P. 1623−1627.
- Corley D.A., Levin T.R., Habel L.A. et al. Surveillance and survival in Barrett’s adenocarcinomas: a population-based study. // Gastroenterology.—2002.—V. 122.—P. 633−640.
- Couper G.W., McAteer D., Wallis F., et al. Detection of response to chemotherapy using positron emission tomography in patients with oesophageal and gastric cancer. // Br. J. Surg.— 1998.— V. 85.— P. 1403−6.
- Daly J.M., Karnell L.H., Menck H.R. National Cancer Data Base report on esophageal carcinoma. //Cancer.— 1996.—V. 78,—P. 1820−1828.
- Daly J.M. Esophageal cancer: results of an American College of Surgeons Patient Care Evaluation Study. // J. Am. Coll. Surg — 2002.— V. 190, — P. 562−572.
- DeCamp M.M., Swanson S.J., Jaklitsch M.T. Esophagectomy After Induction Chemoradiation. 11 CHEST.— 1999.— V. 116, — P. 466−469.
- DeMeester T.R. Clinical biology of the Barrett’s metaplasia, dysplasia to carcinoma sequence. // Surg. Oncol.— 2001.— V. 10.— P. 91−102.
- Dialer H.J., Bollschweiler E., Siewert J.R. Was leistet die Endosonographie im praoperativen Staging des Osophaguskarzinoms? // Dtsch. Med. Wschr.— 1991.—V. 116.—P. 561−566.
- Dittler H.J., Bollschweiller E., Siewart J.R. Was leistet die Endosonographie im praoperativen Staging des Osophaguscarcinomas? // Dtsch. Med. Wochenschr.— 1991.—V. 116.—P. 561.
- Donington J.S., Miller D.L., Allen M.S., Deschamps C., Francis C., Pairolero P.C. Tumor response to induction chemoradiation: influence on survival after esophagectomy. // Eur. J. Cardiothorac. Surg.— 2003.— V. 24, — P. 631−637.
- Doty J. R, Salazar J.D., Forastiere A., Heath E.I., Kleinberg L., Heitmiller R.F. Postoesophagectomy morbidity, mortality, and length of hospital stay after preoperative chemoradiation therapy. // Ann. Thorac. Surg — 2002 — V. 74.— P. 227−231.
- Earlam R., Cuhna-Melo J.R. Oesophageal squamous cell carcinoma. A critical review of radiotherapy. // Br. J. Surg.— 1980, — V. 67.— P. 457−461.
- Earlam R., Cunha-Melo J.R. Oesophageal squamous cell carcinoma. A critical review of surgery. // Br. J. Surg.— 1980, — V. 67.— P. 381−390.
- Endo M., Ide H., Yoshino K., et al. Diagnosis and treatment of early esophageal cancer. In Diseases of the Esophagus, J.R. Siewart, A.H. Holscher, editors. // Tokyo, Springer-Verlag.— 1988, — P. 275−280.
- Enzinger P.C., Ilson D.H., Saltz L.B. et al. Irinotecan and cisplatin for upper gastrointestinal malignancies. // Oncology (Huntingt) 1998.— V. 12(suppl 6).— P. 110−113.
- Fayers P.M., Ashby D., Parmar M.K. Bayesian data monitoring in clinical trials. //Stat. Med.— 1997, — V. 16,—P. 1413−1430.
- Ferguson M., Durkin A. Long-term survival after esophagectomy for Barrett’s adenocarcinoma in endoscopically surveyed and nonsurveyed patients. // J. Gastrointest. Surg .— 2002.— V. 6.— P. 29−35.
- Fisher В., Gunduz N., Coyle J. Presence of a growth stimulating factor in serum following primary tumor removal in mice. // Cancer Res.— 1989.— V. 49.— P. 1996−2001.
- Fisher В., Gunduz N., Saffer E.A. Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases. // Cancer Res.— 1983.—V. 43.—P. 1488−1492.
- Fisher В., Saffer E.A. Deutsch M. Influence of irradiation of a primary tumor on labeling index and estrogen receptor index in a distant tumor focus. // Int. J. Radiat. Oncol. Biol. Phys.— 1986.— V. 12.— P. 879−885.
- Fitzgerald R.C., Saeed I.T., Khoo D. et al. Rigorous surveillance protocol increases detection of curable cancers associated with Barrett’s esophagus. // Dig. Dis. Sci.— 2001.— V. 46.— P. 1892−1898.
- Flamen P., Lerut A., Van Cutsem E., et al. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. //J. Clin. Oncol.—2000.—V. 18.—P. 3202−3210.
- Fockens P., Kisman K., Merkus M.P., van Lanschot J.J., Obertop H., Tytgat G.N. The prognosis of esophageal carcinoma staged irresectable (T4) by endosonography. //J. Am. Coll. Surg.— 1998,—V. 186.—P. 17−23.
- Fok M., Sham J.S., Choy D. et al. Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomized controlled study. // Surgery.— 1993.—V. 113.—P. 138−147.
- Fok M., McShane J., Law S., Wong J. Prospective randomized study of radiotherapy and surgery in the treatment of oesophageal carcinoma. // Asian Journal of Surgery.— 1994.— V. 17.— P. 223−229.
- Forastiere A., Urba S. Combined modality therapy for cancer of the esophagus. //Princ. Pract. Oncol. Updates — 1996.—V. 10.— P. 11−15.
- Forastiere A.A., Gennis M., Orringer M.B., Agha F.P. Cisplatin, vinblastine and mitoguazone chemotherapy for epidermoid and adenocarcinoma of the esophagus. //J. Clin. Oncol.— 1987.—V. 5.—P. 1143−1149.
- Forastiere A.A., Heitmiller R., Kleinberg L., et al. Long follow-up of patients with esophageal cancer treated with preoperative cisplatin/5-FU and concurrent radiation. // Proc. ASCO.— 1999, — V. 18.— 270a.
- Franklin R., Steiger Z., Vaishampayan G., Asfaw I., Rosenberg J., Loh J. et al. Combined modality therapy for esophageal squamous cell carcinoma. // Cancer.— 1983.—V. 51.—P. 1062−1071.
- Geh J.I., Bond S.J., Bentzen S.M., Glynne-Jones R. Preoperative chemoradi other ару in esophageal cancer: evidence of dose response. // Proc. ASCO.—2000.—V. 19,—247a.
- Geh J.I., Crellin A.M., Glynne-Jones R. Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancer. // Br. J. Surg.— 2001.— V. 88.— P. 338−356.
- Giedl J., Dworak O. Anatomische Grenzen der Endosonographie im Gastrointestinal trakt aus der Sicht des Pathologen. // Endoskopie heute.— 1989.— V. 3.— P. 44−48.
- Gignoux M., Roussel A., Paillot В., et al. The value of preoperative radiotherapy in esophageal cancer: results of a study of the E.O.R.T.C. // World J. Surg.— 1987,—V. 11,—P. 426−432.
- Giri P.G.S., Kimler B.F., Giri U.P., Cox G.G., Reddy E.K. Comparison of single, fractionated and hyperfractionated irradiation on the development of normal tissue damage in rat lung. // Int. J. Radiat. Oncol. Biol. Phys.— 1985.— V. 11.— P. 527−534.
- Goldie J.H., Coldman A.J. A mathematical model for relating drug sensitivity of tumors and their spontaneous mutation rate. // Cancer Treat. Rep.— 1979.—V. 63.—P. 1727−1730.
- Greene F.L., Page D.L., Fleming I.D. et al., eds. AJCC Cancer Staging Manual, Sixth Edition. // New York, Springer 2002.— P. 101−118.
- Grimm H., Binmoeller K.F., Hamper K., Koch J., Henne-Bruns D., Sohendra N. Endosonography for preoperative locoregional staging of esophageal and gastric cancer. // Endoscopy.— 1993.— V. 25.— P. 224.
- Grimm H., Soehemtra N., Hamper K. et al. Beitrag der Endosonographie zum praoperativen Staging bei Oesophagus and Magencarcinom. // Chirurg.— 1989,—V. 60.—P. 684−689.
- Grimm H., Sollano J., Hamper K., et al. Endoscopic ultrasound (EUS) of esophagogastric cancer: a new requirement for preoperative staging abstract.?// Gastrointest. Endosc.— 1988.—V. 34.— 176A.
- Guillem P., Fabre S., Mariette C. and Triboulet J. P. Surgery after induction chemoradiotherapy for oesophageal cancer. // EJSO.— 2003.— V. 29.— P. 158−165.
- Gunduz N., Fisher В., Saffer E.A. Effect of surgical removal on the growth and kinetics of residual tumor. // Cancer Res.— 1979.— V. 39.— P. 3861−3865.
- Hadzijahic N., Wallace M.B., Hawes R.H., et al. CT or EUS for the initial staging of esophageal cancer? A cost minimization analysis. // Gastrointest. Endosc.— 2000,—V. 52.—P. 715−720.
- Hagen J.A., DeMeester S.R., Peters J.H. et al. Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies. // Ann. Surg.—2001.— V. 234,—P. 520−530.
- Hagry O., Bernard В., Cheynel N., Benoit L., Rat P., Favre J.P. Influence of neoadjuvant chemoradiotherapy on postoperative morbidity and mortality of oesophageal cancer resection. //J. Chir. Thorac. Cardio-Vasc.— 2001.— V. 3.— P. 153−157.
- Harris D.T., Mastrangelo M.I. Theory and application of early systemic therapy. // Semin. Oncol.— 1991.—V. 18.—P. 498−503.
- Heath E.I., Burtness B.A., Heitmiller R.F. Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus. // J. Clin. Oncol.— 2000.— V. 18,—P. 868−876.
- Heath E.I., Limburg P. J., Hawk E.T. et al. Adenocarcinoma of the esophagus: risk factors and prevention. // Oncology.— 2000.— V. 14.— P. 507−514.
- Heidecke C., Weighardt H., Feith M., Fink U., Zimmermann F., Stein H.J., Siewert J.R., Holzmann B. Neoadjuvant treatment of esophageal cancer: Immunosuppression following combined radiochemotherapy. // Surgery.— 2002.—V. 132,—P. 495−501.
- Heidemann J., Schilling M.K., Schmassmann A. et al. Accuracy of endoscopic ultrasonography in preoperative staging of esophageal carcinoma. // Dig. Surg.—2000,—V. 17,—P. 219−224.
- Heintz A., Mildenberger P., Georg M., Braunstein S., Junginger Th. Endoscopic ultrasonography in the diagnosis of regional lymph nodes in esophageal and gastric cancer results of studies in vitro. // Endoscopy.— 1993.— V. 25 (3).—P. 231−235.
- Hermanek P., Sobin L.H., eds. UICC TNM Classification of Malignant Tumors, 5th revised edition.— Berlin, Springer Verlag, 1992.
- Hermanek P. Magenkarzinom-Prakanzerosen, Klassifikation und Prognose. // In Magenarzinom, J Hotz, HJ Meyer, HJ Schmoll, editors.— Berlin, Springer-Verlag, 1989.—P. 16−27.
- Herskovic A., Martz K., al-Sarraf M. et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. //N. Engl. J. Med.— 1992.—V. 326.—P. 1593−1598.
- Hildebrandt U., Feifel G.— P. Endosonography in the diagnosis of lymph nodes. //Endoscopy.— 1993.—V. 25.—P. 243.
- Holscher A.H., Bollschweiler E., Bumm R. et al. Prognostic factors of resected adenocarcinoma of the esophagus. // Surgery.— 1995.— V. 118.— P. 845−855.
- Hordijk M.L., Zander H., Van B.M., Tilanus H.W. Influence of tumor stenosis on the accuracy of endosonography in preoperative T staging of esophageal cancer. // Endoscopy.— 1993, — V. 25 (2).— P. 171−175.
- Hosch S.B., Stoecklein N.H., Pichlmeier U. et al. Esophageal cancer: the mode of lymphatic tumor cell spread and its prognostic significance. // J. Clin. Oncol.—2001.—V. 19,—P. 1970−1975.
- Huang G.J., Gu X.Z., Wang L.J. et al. Combined preoperative radiation and surgery for esophageal carcinoma. // In: Delarue NC, ed. International Trends in General Thoracic Surgery. St Louis, MO: C.V. Mosby, 1988.—P. 315.
- Hulscher J.B.F., Tijssen J.G.P., Obertop H., Van Lanschot J.J.B. Transthoracic versus transhiatal resection for carcinoma of the oesophagus: a metaanalysis. // Ann. Thorac. Surg.— 2001.— V. 72.— P. 306−313.
- Iizuka Т., Ide H., Kakegawa Т., Sasaki K., Takagi I., Ando N. et al. Preoperative radioactive therapy for esophageal carcinoma. Randomized evaluation trial in eight institutions. // Chest.— 1988.— V. 93.— P. 1054−1058.
- Ilson D.H. New developments in the treatment of esophageal cancer. // Curr. Oncol. Rep.— 2002, — V. 4.—P. 213−221.
- Imdahl A., Bognar G., Schulte-Monting J., Schoffel U., Farthmann E.H., Ihling C. Predictive factors for response to neoadjuvant therapy in patients with oesophageal cancer. // Eur. J. Cardio-thorac. Surg .— 2002.— V. 21.— P. 657−663.
- Imdahl A., Jenkner J., Ihling C., Ru’ckauer K.D., Farthmann E.H. Is MIB-1 proliferation index a predictor for response of neoadjuvant therapy in patients with esophageal cancer?// Am J Surg 2000.— V. 179.— P. 514−520.
- Izbicki J.R., Hosch S.B., Pichlmeier U. et al. Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. // N. Engl. J. Med.— 1997.— V. 337.— P. 1188−1194.
- Jacques Van Dam. Endosonographie Evaluation of the Patient With Esophageal Cancer. // CHEST.— 1997.— V. 112.— 184S-190S.
- Japanese Esophageal Oncology Group. A comparison of chemotherapy and radiotherapy as adjuvant treatment to surgery for esophageal carcinoma. // Chest.— 1993,—V. 104.—P. 203−207.
- Japanese Society for Esophageal Diseases Guide Lines for the Clinical and Pathologic Studies on Carcinoma of the Esophagus. // Tokyo: Kanehara (in Japanese), 1999.
- Jemal A., Thomas A., Murray Т., et al. Cancer statistics 1999. // CA Cancer J. Clin.— 2002.— V. 52, — P. 23−47.
- John M.J., Flam M.S., Mowry P.A., Podolsky W.J., Xavier A.M., Wittlinger P. S. et al. Radiotherapy alone and chemoradiation for nonmetastatic esophageal carcinoma. A critical review of chemoradiation. // Cancer.— 1989.— V. 63,—P. 2397−2403.
- John W.C., Melvyn Goldberg, Multimodality therapy for resectable cancer of the thoracic esophagus. // Ann. Thorac. Surg.— 2002.— V. 73, — P. 1009−1015.
- Jones D.R., Detterbeck F.C., Egan T.M., Parker L.A. Jr, Bernard S.A., Tepper J.E. Induction chemoradiotherapy followed by esophagectomy in patients with carcinoma of the esophagus. //Ann. Thorac. Surg.— 1997.— V. 64.— P. 185−192.
- Jones D.R., Parker L.A. Jr, Detterbeck F.C., Egan T.M. Inadequacy of computed tomography in assessing patients with esophageal carcinoma after induction chemoradiotherapy. // Cancer.— 1999.— V. 85 — P. 1026−1032.
- Karl R.C., Schreiber R., Boulware D., Baker S., Coppola D. Factors affecting morbidity, mortality, and survival in patients undergoing Ivor Lewis esophagogastrectomy. // Ann. Surg.— 2000.— V. 231.— P. 635−643.
- Kato H., Kuwano H., Nakajima M. et al. Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma. // Cancer.— 2002.— V. 94.— P. 921−928.
- Kato H., Kuwano H., Nakajima M. et al. Usefulness of positron emission tomography for assessing the response of neoadjuvant chemoradiotherapy in patients with esophageal cancer. // Am. J. Surg.— 2002.— V. 184.— P. 279−283.
- Keane T.J., Harwood A.R., Elhakim T. et al. Radical radiation therapy with 5-fluorouracil infusion and mitomycin С for oesophageal squamous carcinoma. //Radiother. Oncol.— 1985,—V. 4.—P. 205−210.
- Kelsen D., Hilaris В., Coonley C., et al. Cisplatin, Vindesin and Bleomycin chemotherapy of local-regional and advanced esophageal carcinoma. // Am. J. Med.— 1983, — V. 75.— P. 645−652.
- Kelsen D.P., Ginsberg R., Pajak T.F., et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. // N. Engl. J. Med.— 1998,—V. 339.—P. 1979−1984.
- Kelsen D.P., Hilaris В., Martini N. Neoadjuvant chemotherapy and surgery of cancer of the esophagus. // Semin. Surg. Oncol.— 1986.— V. 2.— P. 170−6.
- Kelsen D.P., Minsky В., Smith M., Beitler J., Niedzwiecki D., Chapman D. Preoperative therapy for esophageal cancer: a randomized comparison of chemotherapy versus radiation therapy. // J. Clin. Oncol.— 1990.— V. 8.— P. 1352−1361.
- Keresztes R.S., Port J.L., Pasmantier M.W., Korst RJ., Altorki N.K. Preoperative chemotherapy for esophageal cancer with paclitaxel and carboplatin: Results of a phase II trial. //J. Thorac. Cardiovasc. Surg.—2003,—V. 126.—P. 1603−1608.
- Khushalani N.I., Leichman C.G., Proulx G. et al. Oxaliplatin in combination with protracted-infusion fluorouracil and radiation: report of a clinical trial for patients with esophageal cancer. // J. Clin. Oncol — 2002 — V. 20.— P. 2844−2850.
- Kies M.S., Rosen S.T., Tsang Т.К. et al. Cisplatin and 5-fluorouracilin the primary management of squamous esophageal cancer. // Cancer.— 1987.— V. 60, — P. 2156−2160.
- Kim K., Park S.J., Kim B-T., Lee K.S., Shim Y.M. Evaluation of lymph node metastases in squamous cell carcinoma of the esophagus with positron emission tomography. // Ann. Thorac. Surg.— 2001.— V. 71.— P. 290−294.
- Kimura K., Yamanaka T. Endoscopic ultrasonography in the assessment of depth of invasion of gastric cancer. In: Takemoto T, Kawai К (eds.): Recent Topics of Digestive Endoscopy. Amsterdam, Princeton, 1987.— P. 70−76.
- Кок T.C., von Lanschot J., Siersema P.D., von Overhagen H., Talanus H.V. Neoadjuvant chemotherapy in operable esophageal squamous cell cancer: final report of a phase III multicenter randomized controlled trial. // Proc. ASCO.— 1997.— V. 16.—277a.
- Koshy M., Esiashvilli N., Landry J.C., Thomas C.R., Matthews R.H. Epidemiology, Presentation and Progression, Work-up, and Surgical Approaches. // The Oncologist.— 2004, — V. 9.— P. 137−146.
- Koshy M., Esiashvilli N., Landry J.C., Thomas C.R., Matthews. Multiple Management Modalities in Esophageal Cancer: Combined Modality Management Approaches. // The Oncologist.— 2004, — V. 9, — P. 147−159.
- Kouzu Т., Ogino Y., Isono K. Endoscopic ultrasonography in esophageal disease. In: Takemoto T, Kawai К (eds.): Recent Topics of Digestive Endoscopy. //Amsterdam, Princeton, 1987.—P. 54−60.
- Krasna M.J., Reed C.E., Hollis D.R., et al. The feasibility of thoracoscopy/laparoscopy in the staging of esophageal cancer: results of a prospective multicenter phase II trial (CALGB 9380). // Proc. ASCO.— 2000.— V. 19, — 239a.
- Laterza E., Manzoni G., Tedesco P., Guglielmi A., Verlato G., Cordiano C. Induction Chemo-Radiotherapy for Squamous Cell Carcinoma of the Thoracic
- Esophagus.— P. Long-Term Results of a Phase II Study. // Ann. Surg. Oncol.— 1999.—V. 6.—№ 8.
- Launois В., Delarue D., Campion J.P., Kerbaol M. Preoperative radiotherapy for carcinoma of the esophagus. // Surg. Gynecol. Obstet.— 1981.— V. 153.—P. 690−692.
- Law S., Fok M., Chow S., et al. Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial. // J. Thorac. Cardiovasc. Surg.— 1997.— V. 114, — P. 210−217.
- Law S., Kwong D.L.W., Tung H.M., et al. Preoperative chemoradiation for squamous cell esophageal cancer: a prospective randomized trial. // Can. J. Gastroenterol.— 1998.— V. 12(Suppl В).— 56B.
- Law S., Wong J. Changing disease burden and management issues for esophageal cancer in the Asia-Pacific region. // J. Gastroenterol. Hepatol.— 2002.—V. 17.—P. 374−381.
- Le Prise E., Etienne P.L., Meunier В., et al. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. // Cancer.— 1994.— V. 73.— P. 1779−1784.
- Lehnert T. Multimodal therapy for squamous carcinoma of the oesophagus. // British J. Surg.— 1999.— V. 86.— V. 6.— V. 727−732.
- Leichman L., Pendyala L., and Leichman C.G. Definitive and Neoadjuvant Therapies for Esophageal and Gastroesophageal Junction Tumors: A Look Back and Toward the Future. // Semin. Oncol.— 2003.— V. 30.— № 4, — S. 11.— P. 11−18.
- Lerut Т., Coosemans W., De Leyn P., Deneffe G., Topal В., Van de Ven
- C., Van Raemdonck D. Reflections on three field lymphadenectomy in carcinoma of oesophageal and gastroesophageal junction. // Hepatogastroenterology.— 1999.— V. 46(26).—P. 717−725.
- Lerut Т., Flamen P., Ectors N., Van Cutsem E., Peeters M., Hiele M., De Wever W., Coosemans W., Decker G., De Leyn P., Deneffe G., Van Raemdonck
- D., Mortelmans L. Histopathologic validation of lymph node staging with FDG
- PET scan in cancer of the oesophagus and gastroesophageal junction: a prospective study based on primary surgery with extensive lymphadenectomy. // Ann. Surg.— 2000.— V. 232.— P. 743−752.
- Lightdale C.J., Botet J.F. Esophageal carcinoma: preoperative staging and evaluation of anastomotic recurrence. // Gastrointest. Endosc.— 1990.— V. 36.— P. 11.
- Lightdale C.J. Positron emission tomography: Another useful test for staging esophageal cancer. // J. Clin. Oncol.— 2000, — V. 18, — P. 3199−3201.
- Luketich J.D., Friedman D.M., Weigel T.L., et al. Evaluation of distant metastases in esophageal cancer: 100 consecutive positron emission tomography scans. // Ann. Thorac. Surg.— 1999.— V. 68, — P. 1133−1136.
- Luketich L.D., Schauer P.R., Landreneau R., et al. Minimally invasive surgical staging is superior to endoscopic ultrasound in detecting lymph node metastases in esophageal cancer. // J. Thorac. Cardiovasc. Surg.— 1997.— V. 114.—P. 817−823.
- Luketich LD, Schauer PR, Meltzer CC, et al. Role of positron emission tomography in staging esophageal cancer. // Ann. Thorac. Surg.— 1997.— V. 64,—P. 765−769.
- Maipang Т., Vasinanukorn P., Petpichetchian C., et al. Induction chemotherapy in the treatment of patients with carcinoma of the esophagus. // J. Surg. Oncol.— 1994.—V. 56.—P. 191−197.
- Mariette C., Castel В., Toursel H., Fabre S., Balon J.M., Triboulet J.P. Surgical management of and long-term survival after adenocarcinoma of the cardia. // Br. J. Surg.— 2002, — V. 89, — P. 1156−1163.
- Mariette С., Balon J.M., Maunoury V., Taillier G., Van Seuningen I. and Triboulet J.P. Value of endoscopic ultrasonography as a predictor of long-term survival in oesophageal carcinoma. // Br. J. Surg.— 2003.— V. 90.— P. 1367−1372.
- Mc Donald J.S., Smalley S.R., Benedetti J., et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of esophagus or gastro esophageal junction. // N. Engl. J. Med.— 2001.— V. 345.— V. 725−730.
- Medical Research Council Oesophageal Cancer Working Party. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomized controlled trial. // Lancet.— 2002, — P. 359.— V. 1727−1733.
- Mei W., Xian-Zhi G., Weibo Y. Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of esophageal carcinoma: report on 206 patients. // Int. J. Radiat. Oncol. Biol. Phys.— 1989.— V. 16.—P. 325−327.
- Montravade R., Ladd Т., Briele H., et al. Carcinoma of the esophagus: Sites of failure. // Int. J. Radiat. Oncol. Biol. Phys.— 1982, — V. 8.— P. 1897−1902.
- Muller J.M., Erasmi H., Stelzner M., Zieren U., Pichlmaier H. Surgical therapy of oesophageal carcinoma. // Br. J. Surg.— 1990.— V. 77.— P. 845−857.
- Murata Y., Muroi M., Yoshida M. et al. Endoscopic ultrasonography in the diagnosis of esophageal carcinoma. // Surg. Endosc.— 1987.— V. 1.— P. 11.
- Murata Y., Suzuku S., Hashimoto H. Endoscopic ultrasonography of the upper gastrointestinal tract. // Surg. Endosc.—. 1988.— V. 2.— P. 180−183.
- Nakayama K., Orihata H., Yamaguchi K. Surgical treatment combined with preoperative concentrated irradiation for esophageal cancer. // Cancer.— 1967.— V. 20.—P. 778−788.
- Nishimaki Т., Tanaki O., Ando N., et al.— P. Evaluation of the accuracy of preoperative staging in thoracic esophageal cancer. // Ann. Thor. Surg.— 1999,—V. 68,—P. 2059−2064.
- Nousbaum J.B., Robaszkiewicz M., Cauvin J.M., Calament G., Gouerou H. Endosonography can detect residual tumour infiltration after medical treatment of oesophageal cancer in the absence of endoscopic lesions. // Gut.— 1992.— V. 33.—P. 1459−1461.
- Okawa Т., Kita M. et al. Results of radiotherapy for inoperable locally advanced esophageal cancer. // Int. J. Radiat. Oncol. Biol. Phys.— 1989.— V. 17.—P. 49−54.
- Parmar M.K., Torri V., Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. // Stat. Med.— 1998.—V. 17.—P. 2815−2834.
- Pedersen Т., Eliasen K., Henriksen H. A prospective study of risk factors and cardiopulmonaiy complications associated with anesthesia and surgeiy: risk indicators of pulmonary morbidity. //Acta Anesthes. Scand.— 1990.— V. 34.— P. 144−155.
- Pera M., Cameron A.J., Trastek V.F., et al. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. // Gastroenterology.— 1993.— V. 104.— P. 510−513.
- Pfau P.R., Ginsberg G.G., Lew R.J., Brensinger C.M., Kochman M.L. EUS predictors of long-term survival in esophageal carcinoma. // Gastrointest. Endosc.— 2001.— V. 53.—P. 463−469.
- Pouliquen X., Levard H., Hay J.M., McGee K., Fingerhut A., Langlois-Zantin O. 5-Fluorouracil and cisplatin therapy after palliative surgical resection of squamous cell carcinoma of the esophagus. // Ann. Surg.— 1996.— V. 223.— P. 127−133.
- Reed C.E. Cancer of the esophagus: clinical presentation and stricture management. // In Roth JA, Ruckdeschel JC, Weisenburger TH, eds. 2 ed. Thoracic oncology. Philadelphia: W.B. Saunders Co., 1995.
- Refaely Y., Krasna M.J. Multimodality therapy for esophageal cancer. // Surg. Clin. North Am.— 2002, — V. 82, — P. 729−746.
- Rice T.W., Blackstone E.H., Goldblum J.R., DeCamp M.M., Murthy S.C., Falk G.W., et al. Superficial adenocarcinoma of the esophagus. // J. Thorac. Cardiovasc. Surg.—2001,—V. 122,—P. 1077−1090.
- Roder J.D., Busch R., Stein H.J. et al. Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus. // Br. J. Surg.— 1994,—V. 81.—P. 410−413.
- Romagnuolo J., Scott J., Hawes R.H., et al. Helical CT versus EUS with fine needle aspiration for celiac nodal assessment in patients with esophageal cancer. // Gastrointest. Endosc.— 2002, — V. 55.— P. 648−654.
- Roussel A., Haegele P., Paillot B. et al. Results of the EORTC-GTCCG Phase III trial of irradiation vs irradiation and CDDP in inoperable esophageal cancer. //Proc. ASCO.— 1994.—V. 13.—P. 30.
- Sampliner R.E. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett’s esophagus. // Am. J. Gastroenterol.— 2002.— V. 97.— P. 1888−1895.
- Schlag P.M. Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. // Arch. Surg.— 1992, — V. 127, — P. 1446−1450.
- Shields T.W., Rosen S.T., Hellerstein S.M., Tsang Т., Ujiki G.T., Kies M.S. Multimodality approach to treatment of carcinoma of the esophagus. // Arch. Surg.— 1984, — V. 119.—P. 558−562.
- Siewart J.R., Roder J.D. Chirurgische Therapie des Plattenepithelcarcinoms des Oesophagus—erweiterte Radikalitat. // Langebecks Arch. Chir.— 1987.—V. 372.—P. 129.
- Siewert J.R., Stein H.J., Fink U. Multimodality Therapy for Esophageal Cancer. // The Oncologist.— 1996.—V. 1.—P. 210−218.
- Siewert J.R., Fink U., Beckurts K.T.E., Roder J.D. Surgery of squamous cell carcinoma of the esophagus. // Ann. Oncol.— 1994.— V. 5.— S. 3.— P. 1−7.
- Skinner D.B., Fergusson M.K., Soriano A., et al. Selection of operation for esophageal cancer based on staging. // Ann. Surg.— 1986.— V. 204.— P. 391.
- Slater M.S., Holland J., Faigel D.O. et al. Does neoadjuvant chemoradiation downstage esophageal carcinoma?// Am. J. Surg.— 2001.— V. 181.— P. 440−444.
- Sobin L.H., Wittekind C., editors. TNM: classification of malignant tumours. 6th ed. New York, Wiley-Liss, 2002.— P. 60−64.
- Standards of Reporting Trials Group. A proposal for structured reporting of randomized controlled trials. // JAMA.— 1994, — V. 272, 1926−1931.
- Stilidi I., Davydov M., Bokhyan V., Suleymanov E. Subtotal esophagectomy with extended 2-field lymph node dissection for thoracic esophageal cancer. // Eur. J. Cardiothorac. Surg.— 2003.— V. 23— P. 415−420.
- Sugimachi K., Ohno S., Fujishima H. et al. Endoscopic ultrasonographic detection of carcinomatous invasion and of lymph nodes in the thoracic esophagus. // Surgery.— 1990, — V. 107,—P. 366.
- Sumiyama K., Suzuki N., Kakutani H., et al. A novel 3-dimensional EUS technique for real-time visualization of the volume data reconstruction process. // Gastrointest. Endosc.— 2002, — V. 55,—P. 723−728.
- Sun D.R. Ten-year follow-up of esophageal cancer treated by radical radiation therapy: analysis of 869 patients. // Int. J. Radiat. Oncol. Biol. Phys.— 1989.—V. 16,—P. 329−334.
- Sutton P., Clark P. Neo-adjuvant treatment for oesophageal cancer. // GI Cancer.— 2000.—V. 3,—P. 231−238.
- Swisher S., Holmes E., Hunt K., Doty J., Zinner M., McFadden D. The role of neoadjuvant therapy in surgically respectable oesophageal cancer. // Arch. Surg.— 1996.—V. 131,—P. 819−825.
- Sykes A.J., Burt P.A., Slevin N.J. et al. Radical radiotherapy for carcinoma of the oesophagus: an effective alternative to surgery. // Radiother. Oncol.— 1998.—V. 48,—P. 15−21.
- Tio T.L., Coene P.P., Den Hartog Jager, Tytgat G.N. Preoperative classification of esophageal carcinoma by endosonography. // Hepatogastroenterology.— 1990.— V. 37.— P. 376.
- Tio T.L., Coene P.P. et al. Esophagogastric carcinoma: preoperative TNM classification with endosonography. // Radiology 1989.— V. 173.— P. 411.
- Tio T.L., Coene P.P., Tytgat G.N. Endosonography in the clinical staging of esophageal carcinoma. // Gastrointest. Endosc.— 1990.— V. 36.— P. 2.
- Tio T.L., Tytgat G.N.J. Atlas of Transintestinal Ultrasonography. Aalsmeer, // The Netherlands, Drukkerij Mur. Kosteur loren, 1986.
- Tio T.L., Tytgat G.N.J. Endoscopic ultrasonography in the assessment of intra-and transmural infiltration of tumors in the esophagus, stomach, papilla of Vater in the detection of extra-oesophageal lesions. // Endoscopy.— 1984.— V. 16.— P. 203.
- To T.L., Cohen P., Coene P.P. et al. Endosonography and computed tomography of esophageal carcinoma. // Gastroenterology.— 1989.— V. 96.— P. 1478−1486.
- Triboulet J.P., Amrouni H., Guillem P., Vandenhaute В., Lecomte-Houcke M., Adenis A. Long term results of esophageal epidermoid cancer with complete remission to preoperative chemo-radiotherapy. // Ann. Chir.— 1998.— V. 52.— P. 503−508.
- Tsurumaru M., Kajiyama Y., Udagawa H., Akiyama H. Outcomes of extended lymph node dissection for squamous cell carcinoma of the thoracic oesophagus. // Ann. Thorac. Cardiovasc. Surg.— 2001.— V. 7.— P. 325−329.
- Union Internacional Contra la Cancrum. TNM Classification. // 5th edn. Heidelberg. Springer, 1997.
- Urba S.G., Orringer M.B., Perez-Tamayo C., et al. Concurrent preoperative chemotherapy and radiation therapy in localized esophageal adenocarcinoma. // Cancer.— 1992.— V. 69.— P. 285−291.
- Urba S.G., Orringer M.B., Turrisi A., et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. // J. Clin. Oncol.— 2001.— V. 19.— P. 303−313.
- Urschel J.D., Vasan H., Blewett C.J. A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for respectable esophageal cancer. // Am. J. Surg.— 2002 — V. 183 — P. 274−279.
- Van der Maase J., Overgaard J., Vaerth M. Effect of cancer chemotherapeutic drug on radiation-induced lung damage in mice. // Radiother. Oncol.— 1986,—V. 5,—P. 245−257.
- Van D.J., Rice T.W., Catalano M.F., Kirby Т., Sivac M.J. High grade malignant stricture is predictive of esophageal tumor stage.— P. risks of Endosonographie evaluation. // Cancer.— 1993.— V. 71 (10).— P. 2910−2917.
- Van Raemdonck D., Van Cutsem E., Menten J. et al. Induction therapy for clinical T4 oesophageal carcinoma- a plea for continued surgical exploration. // Eur. J. Cardiothorac. Surg.— 1997.—V. 11.—P. 828−837.
- Vazquez-Sequeiros E., Wiersema M.J. High-frequency US catheter-based staging of early esophageal tumors. // Gastrointest. Endosc.— 2002.— V. 55.— P. 95−99.
- Vermund H., Pories W.J., Hillard J. et al. Neoadjuvant chemoradiation therapy in patients with surgically treated esophageal cancer. // Acta Oncol.— 2001.—V. 40.—P. 558−565.
- Visbal A.L., Allen M.S., Miller D.L. et al. Ivor Lewis esophagogastrectomy for esophageal cancer. // Ann. Thorac. Surg.— 2001.— V. 71.—P. 1803−1808.
- Vogel S.B., Mendenhall W.M., Sombeck M.D., Marsh R., Woodward E.R. Downstaging of esophageal cancer after preoperative radiation and chemotherapy. //Ann. Surg.— 1995.—V. 221.—P. 685−695.
- Walsh T.N., Noonan N., Hollywood D. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. // N. Engl. J. Med.— 1996.— V. 335.—P. 462−467.
- Wan J., Guo B.Z., Gao S.Z. Accelerated hyperfractionation radiotherapy in esophageal cancer. An analysis of 172 cases. // Chin Med J (Engl).— 1991.— V. 104.—P. 228−229.
- Wang C., Ding Т., Chang L. A randomized clinical study: preoperative chemotherapy for esophageal carcinoma. // Zhonghua Zhong Liu Za Zhi.— 2001.— V. 23.—P. 254−255.
- Weber W.A., Ott K., Becker K. et al. Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. // J. Clin. Oncol.— 2001, — V. 19.— P. 3058−3065.1. Г (c)
- Weiner L.M. Paclitaxel in the treatment of esophageal cancer. // Semin. Oncol.— 1999.—V. 26(Suppl 2).—P. 106−108.
- Willis J., Cooper G.S., Isenberg G., et al. Correlation of EUS measurement with pathologic assessment of neoadjuvant therapy response in esophageal carcinoma. // Gastrointest. Endosc.— 2002.— V. 55.— P. 655−661.
- Wu Y.K., Guo J.H. Surgical treatment In Carcinoma of the Esophagus and Gastric Cardia. // J.H. Guo, J.K. Wu, editors. Tokyo Springer Verlag, 1984, — P. 276−84.
- Xiao Z.F., Yang Z. Y, Liang J., Miao Y.J., Yin W.B., Xian Z.G., Zhang D.C., Wang L.J. Value of Radiotherapy After Radical Surgery for Esophageal Carcinoma: A Report of 495 Patients. // Ann. Thorac. Surg.— 2003.— V. 75.— P. 331- 336.
- Ziegler K., Sanft C., Zeitz M. et al. Evaluation of endosonography in TN staging of esophageal cancer. // Gut.— 1991.— V. 32.— P. 16−20.